Precipio Announces ICEme Kit for Lung Cancer Mutation Detection

Earlier this year, Medgadget heard from Precipio CEO Illan Danieli on how his company uses advanced diagnostics and personalized medicine to reduce the prevalence of cancer misdiagnosis. Over 1 million patients globally and about 200,000 patients in the U.S. are annually diagnosed with non-small cell lung cancer (NSCLC). This week, the company anno (Read more...)

Full Story →